Arcutis Biotherapeutics, Inc. ARQT Common stock, par value (in dollars per share)
Common stock, par value (in dollars per share) at other companies
Other financials
Where this comes from
Reported directly by Arcutis Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.
The official record: Arcutis Biotherapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arcutis Biotherapeutics, Inc.'s common stock, par value (in dollars per share).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arcutis Biotherapeutics, Inc.'s common stock, par value (in dollars per share)?
- Arcutis Biotherapeutics, Inc. (ARQT) reported common stock, par value (in dollars per share) of $0 in Q1 2026.
- How has Arcutis Biotherapeutics, Inc.'s common stock, par value (in dollars per share) changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s common stock, par value (in dollars per share) decreased by 0.0% year-over-year, from $0 to $0.
- What is the long-term trend for Arcutis Biotherapeutics, Inc.'s common stock, par value (in dollars per share)?
- Over 5 years (2020 to 2025), Arcutis Biotherapeutics, Inc.'s common stock, par value (in dollars per share) has grown at a 0.0% compound annual growth rate (CAGR), from $0 to $0.